TokenPost·
DocGo Lowers 2026 Revenue Guidance to About $300 Million
The medical services provider kept its adjusted EBITDA loss forecast at $17 million to $22 million and began a search for a new CEO.
More news
- TokenPostMore Than 100 Solana Validators Apply to Keep Foundation Support
- TokenPostMesa Laboratories Projects $250 Million to $255 Million in Fiscal 2027 Revenue
- TokenPostTong Hsing Proposes S$76.71 Million Buyout of Taiwan-Based, Singapore-Listed GTC
- TokenPostWix Lowers 2026 Free Cash Flow Margin Outlook to About 16%
- TokenPostBitcoin Crosses $74,000, Trades at $74,030 on Binance Spot
- TokenPostWallet Labeled Unknown Transfers 307 Million Tether USDt to Binance